65 Therapeutics
65 Therapeutics is a startup headquartered in Somerville, United States, founded in 2024. It has raised at least $4.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
65 Therapeutics has raised at least $4.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
65 Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Somerville
- 20 Bio
- Addis Energy
- AgZen
- Cala Systems
- Cyvl
- Egal Pads
- Eqore
- Glimpse Engineering
- NeuroBionics
- RF Ultimate Parent
- TalkingHeads Wireless
Related
- Innovation profile of Somerville
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does 65 Therapeutics do?
65 Therapeutics is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has 65 Therapeutics raised?
At least $4.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is 65 Therapeutics based?
65 Therapeutics is headquartered in Somerville, United States.
When was 65 Therapeutics founded?
65 Therapeutics was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.